What is Hippocratic AI?
Safety-focused generative AI agents for non-diagnostic healthcare workflows.
- Category
- Healthcare AI agents
- Headquarters
- Palo Alto, California
- Founded
- 2023
- Employees
- Private; company reported rapid hiring after 2024-2025 funding
- Total funding
- More than $270 million reported
- Valuation
- $1.6 billion reported in 2025
What is Hippocratic AI?
Hippocratic AI is a healthcare ai agents company headquartered in Palo Alto, California.
Hippocratic AI builds healthcare-specific agents for patient-facing administrative and care-support tasks that do not diagnose patients. The company has announced pilots and partnerships across payers, providers, pharmaceutical services, and staffing organizations.
The company was founded in 2023 and remains private. Its public profile is strongest around Healthcare AI agents and Staffing marketplace, while detailed revenue figures are not publicly disclosed.
As of June 2026, the safest public read is that Hippocratic AI is scaling through enterprise partnerships and capital-intensive product development rather than a self-serve consumer motion.
What does Hippocratic AI offer?
Hippocratic AI's public product set centers on Healthcare AI agents, Staffing marketplace, Safety testing.
- Healthcare AI agents· Patient engagement
- Staffing marketplace· Clinical operations
- Safety testing· Model governance
- Voice agents· Care support
Sources:Hippocratic AI website
How does Hippocratic AI make money?
Enterprise AI-agent contracts for healthcare organizations; pricing is not publicly posted.
Enterprise AI-agent contracts for healthcare organizations; pricing is not publicly posted. No public list pricing; sold through enterprise healthcare procurement.
Growth is driven by enterprise adoption, strategic partnerships, and proof that the platform can deliver measurable operational, clinical, scientific, or mission outcomes. Because Hippocratic AI does not publish standard list prices, buyers should treat budget sizing as a custom-contract exercise.
The commercial motion therefore depends on executive sponsorship, security and compliance review, and evidence that the product can integrate into existing workflows rather than replace them all at once.
Who leads Hippocratic AI?
Hippocratic AI is led by Munjal Shah, Co-founder and CEO.
- Munjal ShahCo-founder and CEOCo-founder · since 2023Serial entrepreneur leading healthcare AI strategy.
- Vishal ParikhCo-founderCo-founder · since 2023Healthcare and technology operator.
- Dr. Mehmood KhanBoard/clinical advisorAdvisorFormer life-sciences executive involved in clinical governance.
How do you contact Hippocratic AI's leadership?
Public contact form; no verified personal email pattern found. Use the listed public company route rather than guessed personal inboxes.
Public contact form; no verified personal email pattern foundSources:Hippocratic AI website
How much funding has Hippocratic AI raised?
Hippocratic AI has more than $270 million reported and is private.
2023: Seed — $50 million, led/backed by General Catalyst and Andreessen Horowitz. 2024: Series A — $53 million, led/backed by Premji Invest and General Catalyst ($500 million valuation reported). 2025: Series B — $141 million, led/backed by Kleiner Perkins ($1.64 billion valuation reported). 2025: Strategic extension — $17 million, led/backed by Strategic healthcare investors (Valuation not disclosed).
The latest public valuation/status marker is $1.6 billion reported in 2025. Where a valuation is undisclosed, public reporting only supports the financing amount and participating investors.
Funding is best interpreted as capacity for product build-out, hiring, regulatory or deployment work, and longer sales cycles; it should not be read as proof of profitability unless the company has separately disclosed profitability.
How did Hippocratic AI get here?
Hippocratic AI's timeline runs from its 2023 founding through major financing and product milestones.
- 2023LaunchHippocratic AI launched with a safety-focused healthcare LLM thesis.
- 2023Seed financingThe company raised $50 million from major venture investors.
- 2024Series AThe company became a healthcare AI unicorn candidate as pilots expanded.
- 2025Series B unicorn roundHippocratic AI raised a large round at a reported $1.6 billion valuation.
- 2025Agent marketplaceThe company emphasized AI agents for non-diagnostic patient interactions.
Who are Hippocratic AI's competitors?
Hippocratic AI competes with specialized startups and larger platform companies in healthcare ai agents.
Hippocratic AI — frequently asked questions
